## Requirements # Requirements ## 1. Functional Requirements ### 1.1 Abuse Prevention Measures in Home-Visit Nursing - The responsibilities of administrators at home-visit nursing stations must be clarified and requirements reviewed to ensure quality of provided nursing care and efficient station operation. - Establishment of an abuse prevention system is mandatory, and physical restraints are principally prohibited to promote proper abuse prevention measures and appropriate use of physical restraints in home-visit nursing [KB-01a2d77c-a20a-47e5-ae19-16ab2c89e272], [KB-e14d657a-8970-4e3e-9ccb-5662af7d6525]. ### 1.2 Minimization of Physical Restraints - Measures to minimize physical restraints in medical institutions must be strengthened by requiring the establishment of organizational systems for restraint minimization [KB-edc81296-4474-4138-a404-f797f293eb19], [KB-8445364a-473a-46bc-8207-fb1f2671bde6]. ### 1.3 Nursing Staff Collaboration and Physical Restraint Minimization - Requirements and evaluation for nursing assistant system enhancement must be reviewed to further promote division of labor and collaboration among nursing staff and assistants, as well as initiatives to minimize physical restraints [KB-05c4460e-0933-40a9-962c-fc2be422e060]. ### 1.4 Frequent Visit Additions in Home-Visit Nursing - Requirements and evaluation for frequent visit additions must be reviewed to appropriately promote evaluation based on patient condition in home medical care [KB-17ac1ec0-b2d4-4910-9884-a2e46ea25ce0]. ### 1.5 24-Hour Response System in Home-Visit Nursing - The evaluation system for 24-hour response system additions must be revised to consider initiatives for reducing nursing workload and review the handling of communication systems related to 24-hour response [KB-06db46ba-7647-483b-9f38-f7fa62a24d77]. ### 1.6 Emergency Visit Nursing Additions - Requirements and evaluation for emergency visit nursing additions must be reviewed to ensure appropriate provision of designated emergency home-visit nursing, including revision of claim documentation [KB-4be6a015-623d-440c-95dd-a51bf556ebbd]. ### 1.7 Home-Visit Nursing Management Fee - Requirements and evaluation for home-visit nursing management fee must be reviewed to strengthen the functions of home-visit nursing stations and ensure effective, high-quality care [KB-aeb72a17-5d44-4c8e-b3c6-e83c459da003]. ### 1.8 Online Qualification Confirmation System in Home-Visit Nursing - When an online qualification confirmation system is introduced, planned management of designated home-visit nursing must be performed by obtaining and utilizing user medical and medication information during the initial visit, providing high-quality care [KB-9e53203f-143a-4301-abb8-e7bd7dde87af]. ### 1.9 Terminal Care Additions - Requirements for terminal care additions must be reviewed to support end-of-life care in accordance with patient wishes at their preferred location [KB-3e410501-b1b1-45a9-8876-3e7fcf55b2dd]. ### 1.10 Discharge Support Guidance Additions - Enhance evaluation based on the condition of users and provision status of home-visit nursing on the day of discharge [KB-b375a84b-c77e-4084-a4a2-a2e0f2c22a9a]. ### 1.11 Medication Management and Guidance - Requirements for medication management and guidance must include: - Support for patients in managing medication, including one-package dispensing and necessary guidance [KB-07f1aee1-1797-47ce-a5e9-b2462436b453]. - Information provision to medical institutions based on patient or family request when managing brought-in medications [KB-2f8bb1e8-7cd1-4808-802d-61cbf1dea96e]. - Proposal to prescribing physicians for resolving duplicate prescriptions when identified [KB-f2bbf07b-2196-40f3-9da7-66b45e6dd128], [KB-50d4fc2a-962d-4820-a105-6ba75b15cf4c]. - Guidance for patients with multiple medications or difficulties in self-administration, with physician approval for necessity and support [KB-ff3ce6e4-b5ec-4058-afe5-c24124781336]. ### 1.12 Narcotics Management and Guidance - For patients prescribed narcotics, confirmation of usage, storage, and side effects, and provision of necessary pharmaceutical management and guidance is required. Points are added per instance in accordance with relevant regulations [KB-24385190-0703-42d1-a834-6854e998b904], [KB-ad7d4dc3-8896-4c1b-92c7-8d969120b377], [KB-66969593-ac17-45cd-a41d-f335a2406225], [KB-08876a43-c1e4-4b7f-8517-0cd67e273533], [KB-31de50ce-f3df-4fb0-a0bd-6a1ce5795463], [KB-10f23eda-03d3-4220-8642-6ff7cbf64700]. ### 1.13 Adverse Effect Management - For designated pharmacies meeting facility standards, adverse effect occurrence status and treatment plans must be documented and necessary pharmaceutical management and guidance provided with patient consent [KB-1deff0da-ee71-4c91-9b5b-76f0767d90da], [KB-e8ad7124-d716-4649-9f50-064344c869d7]. ### 1.14 Medication Information Provision - Medication information must be provided to medical institutions, care managers, and prescribing physicians as required, using documentation, and points are added per provision [KB-c35807e4-304e-4ca5-8e86-e1404c20a9fd], [KB-37919876-98a0-4f81-879a-7de2d13e4a0f], [KB-0dc6dd3-3ecc-4685-9f43-b8bcb2ab8ce4], [KB-cd5ee7fe-b23b-4de0-a8e1-f8ff41e250cf]. ### 1.15 Pediatric Specific Additions - For patients defined as disabled children under the Child Welfare Act, necessary information must be directly confirmed with the patient or family, guidance provided, and documentation recorded in a notebook. Pediatric-specific additions are applied [KB-ba91d9ab-b335-4929-9779-694ba115ef39], [KB-6bb697eb-fdad-4cda-a697-9d148e072b9d]. ### 1.16 Inhalation Drug Guidance Additions - For asthma or COPD patients prescribed inhalation drugs, necessary pharmaceutical management and guidance must be provided using documentation and practice inhalers, with information provided to medical institutions. Points are added per instance [KB-604920cd-6896-4a10-97db-9faeb614d499], [KB-ef609548-ff37-4388-9fd5-c638d8bf6eab]. ### 1.17 Special Drug Safety Management Additions - For drugs requiring special safety management, confirmation of usage, side effects, and provision of necessary pharmaceutical management and guidance is required. Points are added per instance [KB-f271747d-fadb-4d69-9ff8-ea0f4702f4f2], [KB-fde2b685-c7c4-44d8-9de7-3a7051dd9005]. ### 1.18 ICT Utilization in Palliative Care - For terminal cancer patients receiving home care, quality palliative care must be provided, utilizing ICT to share end-of-life medical and care information among medical professionals, and physicians must provide necessary guidance based on shared information [KB-fa0fdacb-f933-4296-8d0b-ac501b9102a5], [KB-ef95bdaa-ef0b-4848-bf4b-a5c073be5ba9]. ### 1.19 Online Medication Guidance - When medication guidance is provided via information communication devices, points are added per prescription reception, with exceptions for certain patients [KB-aa54fa9a-3239-4b1e-8e7d-f1996a6420e8], [KB-f77500df-52fe-450b-80c7-cbf364803425]. ## 2. Business Requirements ### 2.1 Calculation of Fees and Additions - Fees and additions for various guidance, management, and information provision activities must be calculated according to the specified points and frequency limitations in the relevant regulations [KB-4fc322f9-642f-4801-89c3-cb70c9af6ab1], [KB-20775cd7-be3a-4a41-a8e2-53ac409c2538], [KB-b2731f14-7331-4d15-827d-89f8aed2bcb1], [KB-5398730a-d7b5-4d8b-830e-5282b5bf61c8], [KB-ffab649b-a67a-4acf-80e1-d2c52ddeea35]. ## 3. Constraints ### 3.1 Frequency and Eligibility Constraints - Certain fees and additions may only be calculated a limited number of times per month or per quarter, and eligibility may be restricted based on facility standards or patient status [KB-473d2d4d-0a06-4fe0-990e-29bef944a7c7], [KB-95340505-f820-4879-9646-0167a0508c15]. ## 4. Quality Requirements ### 4.1 Security and Privacy - Abuse prevention systems and minimization of physical restraints must be implemented to ensure patient safety and dignity. - When using ICT and online systems, patient information must be securely managed and shared only with authorized personnel [KB-fa0fdacb-f933-4296-8d0b-ac501b9102a5], [KB-ef95bdaa-ef0b-4848-bf4b-a5c073be5ba9]. [GAP: Missing data for Requirements] (if further detail or specific requirements are needed beyond those cited above) --- **References:** All requirements are directly derived from the following knowledge base blocks: [KB-01a2d77c-a20a-47e5-ae19-16ab2c89e272], [KB-e14d657a-8970-4e3e-9ccb-5662af7d6525], [KB-edc81296-4474-4138-a404-f797f293eb19], [KB-8445364a-473a-46bc-8207-fb1f2671bde6], [KB-05c4460e-0933-40a9-962c-fc2be422e060], [KB-17ac1ec0-b2d4-4910-9884-a2e46ea25ce0], [KB-06db46ba-7647-483b-9f38-f7fa62a24d77], [KB-4be6a015-623d-440c-95dd-a51bf556ebbd], [KB-aeb72a17-5d44-4c8e-b3c6-e83c459da003], [KB-9e53203f-143a-4301-abb8-e7bd7dde87af], [KB-3e410501-b1b1-45a9-8876-3e7fcf55b2dd], [KB-b375a84b-c77e-4084-a4a2-a2e0f2c22a9a], [KB-07f1aee1-1797-47ce-a5e9-b2462436b453], [KB-2f8bb1e8-7cd1-4808-802d-61cbf1dea96e], [KB-f2bbf07b-2196-40f3-9da7-66b45e6dd128], [KB-50d4fc2a-962d-4820-a105-6ba75b15cf4c], [KB-ff3ce6e4-b5ec-4058-afe5-c24124781336], [KB-24385190-0703-42d1-a834-6854e998b904], [KB-ad7d4dc3-8896-4c1b-92c7-8d969120b377], [KB-66969593-ac17-45cd-a41d-f335a2406225], [KB-08876a43-c1e4-4b7f-8517-0cd67e273533], [KB-31de50ce-f3df-4fb0-a0bd-6a1ce5795463], [KB-10f23eda-03d3-4220-8642-6ff7cbf64700], [KB-1deff0da-ee71-4c91-9b5b-76f0767d90da], [KB-e8ad7124-d716-4649-9f50-064344c869d7], [KB-c35807e4-304e-4ca5-8e86-e1404c20a9fd], [KB-37919876-98a0-4f81-879a-7de2d13e4a0f], [KB-0dc6dd3-3ecc-4685-9f43-b8bcb2ab8ce4], [KB-cd5ee7fe-b23b-4de0-a8e1-f8ff41e250cf], [KB-ba91d9ab-b335-4929-9779-694ba115ef39], [KB-6bb697eb-fdad-4cda-a697-9d148e072b9d], [KB-604920cd-6896-4a10-97db-9faeb614d499], [KB-ef609548-ff37-4388-9fd5-c638d8bf6eab], [KB-f271747d-fadb-4d69-9ff8-ea0f4702f4f2], [KB-fde2b685-c7c4-44d8-9de7-3a7051dd9005], [KB-fa0fdacb-f933-4296-8d0b-ac501b9102a5], [KB-ef95bdaa-ef0b-4848-bf4b-a5c073be5ba9], [KB-aa54fa9a-3239-4b1e-8e7d-f1996a6420e8], [KB-f77500df-52fe-450b-80c7-cbf364803425], [KB-4fc322f9-642f-4801-89c3-cb70c9af6ab1], [KB-20775cd7-be3a-4a41-a8e2-53ac409c2538], [KB-b2731f14-7331-4d15-827d-89f8aed2bcb1], [KB-5398730a-d7b5-4d8b-830e-5282b5bf61c8], [KB-ffab649b-a67a-4acf-80e1-d2c52ddeea35], [KB-473d2d4d-0a06-4fe0-990e-29bef944a7c7], [KB-95340505-f820-4879-9646-0167a0508c15].